Drawing for AI TEAMMATES FOR CLINICAL RESEARCH

USPTO serial 99254794

AI TEAMMATES FOR CLINICAL RESEARCH

Reviewed by CopyMark Law Group

Status 654
Filing date
Status date
Registration date
—
Examiner
GRAJEDA, HECTOR M
Law office
TMO LAW OFFICE 123

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AI TEAMMATES FOR CLINICAL RESEARCH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael Markos

Michael Markos LEGALFORCE RAPC WORLDWIDE, P.C.1580 W. El Camino Real, Suite 10Mountain View, CA 94040United States

Goods and services

ClassDescriptionStatusFirst use
035Business management and consultation in the field of clinical trial operations and clinical research study management for sponsors, contract research organizations (CROs), and clinical research sites, namely, business consultation regarding planning, coordinating, and managing clinical trial study setup and maintenance, clinical site selection and activation, trial monitoring and quality oversight, protocol compliance, patient enrollment visibility, subject identification and recruitment, and clinical trial site financial performance and payment trackingACTIVEOct 27, 2019
042Platform as a service (PAAS) featuring computer software platforms for managing and automating clinical trial operations and clinical research study administration, namely, software platforms for automated study management; study setup and maintenance, real-time centralized monitoring of clinical trial data for trial oversight and decision making, regulatory compliance management and inspection readiness; clinical site selection and activation, real-time visibility into patient enrollment, identifying subjects and recruiting faster, simplifying screening and scheduling, minimizing clinical trial data entry; automating live document updates, and automated payment tracking and follow-up for clinical trial site payments; Scientific research in the nature of conducting clinical trials for othersACTIVEOct 27, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 15, 2026RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Apr 15, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Apr 15, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 15, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 15, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 14, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 14, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Jan 14, 2026CNSLSUSPENSION LETTER WRITTEN—
Jan 14, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 14, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 14, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 19, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 19, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 19, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 14, 2025DOCKASSIGNED TO EXAMINER—
Nov 3, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 26, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 26, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance